In jurisdictions as large and diverse as California, the understanding of health equity and how to apply best practices could not be more pressing. Improving and assuring racial equity above racial equality has been shown to reduce inequity in healthcare outcomes through community-level investment, equitable leadership development, and most importantly increased access to timely and..
The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time, more barriers to success are emerging with requirements for increasingly complex clinical trials, continuous regulatory changes, evolving payer conditions, and more restrictive access to HCPs. It’s..
The Registry is a comprehensive state-wide cancer surveillance program that collects information on cancers diagnosed in California and provides insight to develop strategies and policies for cancer prevention, treatment, and control to promote health equity among Californians living with cancer. We will also honor State Senator Susan Rubio and Assemblymember Mike Gipson for championing legislation on behalf of cancer patients,..
The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time, more barriers to success are emerging with requirements for increasingly complex clinical trials, continuous regulatory changes, evolving payer conditions, and more restrictive access to HCPs. It’s..
Location: Dana Point, CA Convening more than 500 of the world’s leading clinicians, industry executives, investors, patient advocates, payers, policy experts, and researchers, the 16th Annual Personalized Medicine Conference will facilitate a cross-sector exchange of perspectives on the scientific, business, and policy issues influencing the status and outlook for personalized medicine in the wake of a..
The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time, more barriers to success are emerging with requirements for increasingly complex clinical trials, continuous regulatory changes, evolving payer conditions, and more restrictive access to HCPs. It’s..
Join CBHN for a conversation with Jeri Lacks and David Lacks III, of the Henrietta Lacks Family, about their grandmother’s legacy, what the family has done over the years to ensure greater protection for patients in clinical trials, and the Henrietta Lacks Enhancing Cancer Research Act of 2019 and what it means in addressing health..
Location: Virtual The Fierce Leaders in Life Sciences Forum brings together forward-thinking minds from today’s life sciences industry and features insights from C-suite and executive leadership on the end-to-end drug development process, highlighting innovative approaches in today’s evolving healthcare landscape to conducting: R&D and translational science Clinical development Product commercialization Top Reasons to Attend Industry Updates: Hear from..
LABEST - Los Angeles Bioscience Ecosystem Summit 2022 is the premier showcase for bioscience innovation in Los Angeles County produced by UCLA TDG (Technology Development Group) - the tech transfer office for the University. This event is a collaboration with colleagues from across the county to present promising academic research, entrepreneurial faculty investigators, as well..